Literature DB >> 17926800

Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know.

Mellar P Davis1, Wael Lasheen, Pamela Gamier.   

Abstract

Approximately 60% of cancer patients experience pain, and 25% to 30% have severe pain. With some cancers, opioids will be needed before chemotherapy begins and may be more frequently prescribed than chemotherapy. Given the frequency with which pain management is necessary in cancer patients, all oncologists should be familiar with opioid prescribing principles. This article reviews the World Health Organization recommendations for analgesic therapy in this setting, as well as guidelines for opioid therapy in patients with renal failure or hepatic failure, assessment of pain, dosing strategies in both acute and chronic pain, management of opioid overdose, pain associated with dose-limiting side effects, and pain in the actively dying.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926800

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

Review 1.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec

2.  Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Daniel I G Cubero; Auro del Giglio
Journal:  Support Care Cancer       Date:  2009-05-07       Impact factor: 3.603

4.  The use of opioids at the end of life: the knowledge level of Dutch physicians as a potential barrier to effective pain management.

Authors:  Mette L Rurup; Christiaan A Rhodius; Sander D Borgsteede; Manon Sa Boddaert; Astrid Gm Keijser; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2010-11-12       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.